
Blade Air Mobility's year-over-year losses narrowed to $27.26 million on revenues of $146.1 million in 2022 versus a $32 million loss on $67 million in revenues in 2021, it announced today.
The company ended the year with a particularly strong fourth quarter, according to CEO Rob Wiesenthal. "Strong organic growth in MediMobility organ transport coupled with our acquisitions in Europe and Canada drove record revenue and flight profit in 2022. As we navigate a dynamic macro environment, we continue to believe that Blade is well-positioned to thrive in any economic climate, particularly given the non-discretionary nature of our medical business, the resilience of our fliers, and the supply flexibility afforded by our asset-light model," he said. In addition to organic growth, increased revenues were the result of higher prices and acquisitions, including Blade Europe and Blade Canada.